The indications for placement of an implantable cardioverter defibrillators (ICDs) have greatly expanded over the last years. However, standard transvenous approach is not suitable for a subset of patients who cannot benefit from ICD therapy. Here, we have demonstrated the feasibility and efficacy of extrapericardial ICD placement through a minimally invasive access in intact hearts as well as in postmyocardial infarction large animal models. Based on our data, we conclude that extrapericardial ICD placement is a feasible approach that may be a valuable alternative or adjunct to current defibrillator lead systems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-0037-1601313 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!